NexLife resource center
Every NexLife guide in one place: what compounded tirzepatide and semaglutide cost, how online programs compare, how to take them safely, and what’s changing with coverage and new drugs. Each guide cites its sources and shows when its prices were checked.
Good places to start: what it costs, which program, and which medication.
Compounded tirzepatide costs $139 to $399 a month online (median $237) and semaglutide $119 to $299 (median $199), month to month, checked November 1, 2026.
At LillyDirect, Zepbound costs $299 a month at 2.5 mg, rising to $449 from 7.5 mg with a refill within 45 days, or $499 to $699 (checked November 1, 2026).
The best tirzepatide providers depend on your need: LillyDirect for brand-name Zepbound, Ro for insurance checks, PreventiveMD for $139 a month, Rx.com for no auto-renewal (checked November 1, 2026).
The best semaglutide providers depend on your need: NovoCare for brand-name Wegovy, Ro for insurance checks, PreventiveMD for $119 a month, Rx.com for no auto-renewal (checked November 1, 2026).
Seven free tools: BMI first, then BMR and TDEE for the calories you burn, a calorie deficit target and protein.
In SURMOUNT-5, the head-to-head trial, tirzepatide led to more weight loss than semaglutide: 20.2% versus 13.7% on average over 72 weeks (The New England Journal of Medicine, 2025).
What tirzepatide and semaglutide cost per month, by dose and by program, for brand-name and compounded versions.
At LillyDirect, Zepbound costs $299 a month at 2.5 mg, rising to $449 from 7.5 mg with a refill within 45 days, or $499 to $699 (checked November 1, 2026).
A month of compounded tirzepatide costs $139 to $399 online in our price index (median $237); Zepbound costs $299 to $699 at LillyDirect, by dose and refill timing (checked November 1, 2026).
Compounded tirzepatide costs $139 to $399 a month online (median $237) and semaglutide $119 to $299 (median $199), month to month, checked November 1, 2026.
Of 26 programs we checked, the cheapest month-to-month compounded semaglutide is PreventiveMD’s $119; CoreAge Rx advertises a lower $79 but doesn’t state the plan length (checked November 1, 2026).
The cheapest compounded tirzepatide at regular all-in prices in our 14-program index is Cora’s 12-month plan at $135 a month or PreventiveMD’s month-to-month plan at $139 (checked November 1, 2026).
Compounded tirzepatide costs $139 to $399 a month online, month to month and all in, median $237 across 14 programs (checked November 1, 2026).
Compounded semaglutide costs $119 to $299 a month online, all in, with a $199 median across 17 programs (checked November 1, 2026).
Self-pay, the Wegovy pen costs $349 a month ($399 at 7.2 mg) after two $199 fills; compounded semaglutide costs $119 to $299 in our price index (checked November 1, 2026).
First-month tirzepatide deals end in month two: Noom goes $149 to $299, Remedy Meds $279 to $399, Shapely $298 to $348 (checked November 1, 2026).
At NovoCare, Wegovy’s 0.25 and 0.5 mg starter fills are $199, then every pen dose up to 2.4 mg is $349 (checked November 1, 2026).
Without insurance, Zepbound costs $299 to $699 per 28-day supply at LillyDirect, by dose and refill timing (checked November 1, 2026).
Five of 14 tirzepatide programs in our price index charge under $200 a month, month to month, care included: $139 to $199 (checked November 1, 2026).
In trials, tirzepatide (Zepbound) led to the most weight loss; in our price index, compounded semaglutide costs least, at $119 to $299 a month (checked November 1, 2026).
Five of 17 semaglutide programs in our GLP-1 price index publish a lower month-one price, then charge $50 to $150 more (checked November 1, 2026).
Of 26 semaglutide programs we checked on November 1, 2026, 14 cost under $200 a month, all in.
With commercial coverage, Lilly’s Zepbound savings card, the manufacturer’s coupon, can bring a single-dose pen fill to as little as $25, saving up to $100 a month.
Novo says Wegovy’s list price drops from $1,349.02 to $675 a month on January 1, 2027, and self-pay prices ($349–$399 pens, $149–$299 pills) aren’t affected.
Tirzepatide already got cheaper: Zepbound fell to $299–$449 a month at LillyDirect in December 2025, with no new cut announced as of November 1, 2026.
Without insurance, the Ozempic pen costs $349 a month at Novo Nordisk’s self-pay price ($499 at 2 mg), and the pill $149 to $299 (checked November 1, 2026).
BMI, BMR, TDEE, calorie deficit, protein and GLP-1 dose calculators, each with the formula it uses and what your number means.
Seven free tools: BMI first, then BMR and TDEE for the calories you burn, a calorie deficit target and protein.
Zepbound and Wegovy are approved for adults with a BMI of 30 or more, or 27 or more with a weight-related condition.
Your BMR is the calories you burn at rest. The Mifflin-St Jeor equation gives a 40-year-old woman, 5 ft 7 in and 200 lb, about 1,610 calories a day.
TDEE is the calories you burn in a day: BMR × 1.2 to 1.9. For a moderately active woman of 40, 5 ft 7 in and 200 lb, that’s 2,495 calories.
Eat about 500 calories a day below your maintenance calories (TDEE) to lose about 1 lb a week, by the classic math.
The adult protein RDA is 0.8 g per kg of body weight a day. Losing weight? 1.2 to 1.6 g per kg.
Units = dose in mg ÷ vial strength in mg/mL × 100 on a U-100 syringe. At an example 25 mg/mL, 2.5 mg of tirzepatide is 0.1 mL, or 10 units.
Without insurance, without a membership, three months at a time, in installments, or with your HSA or FSA.
Nine programs in our price index offer compounded tirzepatide without a membership, at $139 to $399 month to month (checked November 1, 2026).
Yes: some online programs take Afterpay or Klarna for tirzepatide, and pay in 4 splits a $169 charge into four payments of $42.25, two weeks apart (checked November 1, 2026).
Nine of the 14 tirzepatide programs we track charge one price at every dose: $139 to $399 month to month (checked November 1, 2026).
Without insurance, compounded tirzepatide costs $139 to $399 a month online in our price index, and Zepbound costs $299 to $699 at LillyDirect, by dose and refill timing (checked November 1, 2026).
Ivím Health adds a $75 monthly membership, Mochi Health $79, and Alloy and Shapely $99, while ten programs charge none (checked November 1, 2026).
Without insurance, compounded semaglutide costs $119 to $299 a month online in our price index, and Wegovy $149 to $399 self-pay, pill or pen (checked November 1, 2026).
Flat-rate semaglutide means one price at every dose, and 10 of the 17 programs in our price index charge that way (checked November 1, 2026).
Yes: an HSA or FSA can pay for compounded tirzepatide prescribed for a diagnosed disease, such as obesity, not appearance; 2026 limits: HSA $4,400 self-only, FSA $3,400 (checked November 1, 2026).
Yes: an HSA or health FSA can pay for compounded semaglutide prescribed for a diagnosed disease, such as obesity; 2026 limits: HSA $4,400 and FSA $3,400 (checked November 1, 2026).
Yes: NexLife takes Affirm, Klarna and Afterpay at checkout for compounded semaglutide, $119 a month on the 12-month plan or $139 month to month (prices checked November 1, 2026).
Without insurance, brand-name GLP-1s cost $149 to $499 a month at the makers’ self-pay prices, with refills within 45 days (checked November 1, 2026).
You can appeal, switch to a covered GLP-1 or pay cash: in November 2026, Zepbound runs $299 to $449 a month and Wegovy pens $349.
A 3-month supply of compounded tirzepatide costs $477 to $896 in total at the programs we compared (checked November 1, 2026).
A 3-month supply of compounded semaglutide costs $339 to $837 in our GLP-1 price index (checked November 1, 2026), usually in one charge, not always in one shipment.
Programs rated side by side, how to check a provider and its pharmacy, and how to switch without starting over.
The best tirzepatide providers depend on your need: LillyDirect for brand-name Zepbound, Ro for insurance checks, PreventiveMD for $139 a month, Rx.com for no auto-renewal (checked November 1, 2026).
The best semaglutide providers depend on your need: NovoCare for brand-name Wegovy, Ro for insurance checks, PreventiveMD for $119 a month, Rx.com for no auto-renewal (checked November 1, 2026).
There’s no single best tirzepatide compounding pharmacy, but a good one is a state-licensed 503A pharmacy.
You can switch GLP-1 providers mid-treatment: bring your prescription, your dose and, for a price match, a receipt from the last 60 days; a provider continues your dose when appropriate.
No tirzepatide provider is right for everyone: three questions on insurance, budget and care match you to one of 11 programs (checked November 1, 2026).
You can switch semaglutide providers mid-treatment; with proof of your current dose, your new provider can continue it when clinically appropriate instead of restarting you at 0.25 mg.
There’s no single best semaglutide compounding pharmacy, but a good one is a state-licensed 503A pharmacy.
You need a prescription: licensed telehealth programs sell compounded semaglutide for $119 to $299 a month in our price index (checked November 1, 2026).
The best online tirzepatide program depends on your needs: of the 24 we rated, PreventiveMD has the lowest month-to-month price, $139 at every dose (checked November 1, 2026).
You need a prescription: licensed telehealth programs in our price index sell compounded tirzepatide for $139 to $399 month to month, and LillyDirect sells Zepbound (checked November 1, 2026).
Clinics often bill visits and medication separately; online, compounded tirzepatide in our price index costs $139 to $399 month to month, all in, median $237 (checked November 1, 2026).
A legit tirzepatide provider has a licensed prescriber review you first, and a state-licensed pharmacy fill your prescription: 2 of the 6 checks you can run yourself.
The best online semaglutide program depends on your needs: of the 26 we rated, PreventiveMD has the lowest month-to-month price, $119 at every dose (checked November 1, 2026).
Switching from Zepbound to compounded tirzepatide takes a licensed provider’s prescription; self-pay Zepbound costs $299 to $699 per 28 days, by dose and refill timing (checked November 1, 2026).
You can switch from Wegovy to compounded semaglutide if a licensed provider prescribes it; Wegovy’s pen is $349 a month, $399 at 7.2 mg (checked November 1, 2026).
Online, a licensed prescriber reviews your health first; self-pay, brand-name GLP-1s cost $149 to $699 a month, compounded ones $119 to $399 in our index (checked November 1, 2026).
Reviews of each program and its alternatives: prices, what you get, and who each one fits.
Embody’s regular month-to-month price is $349 for compounded tirzepatide, $299 for semaglutide (checked November 1, 2026); Trustpilot rates it 3.9 from 11,253 reviews.
Wellmedr advertises compounded tirzepatide from $71 a month and semaglutide from $41 on a Pre-Black Friday sale, but we couldn’t find its regular price (read November 1, 2026).
Mondae lists compounded tirzepatide at $126 a month and semaglutide $87, at every dose (checked November 1, 2026); Trustpilot showed 3.4 from 330 reviews on November 1, 2026.
Mochi Health prices its medication by dose: compounded tirzepatide starts at $169 a month and semaglutide at $139, its $79 monthly membership included (checked November 1, 2026).
Hims adds a required membership to brand-name GLP-1s ($39 the first month, then $149), while LillyDirect and NovoCare sell Zepbound and Wegovy without one (checked November 1, 2026).
Ro prescribes brand-name Zepbound at $448 to $598 a month and Wegovy at $298 to $548, its $149 monthly membership included (checked November 1, 2026).
MEDVi’s tirzepatide page lists its tirzepatide injection at $166 a month, price-locked, but that page’s FAQ says $199 (checked November 1, 2026).
Remedy Meds charges $279 for your first 4 weeks of compounded tirzepatide, then $399 every 4 weeks (checked November 1, 2026): 13 charges and $5,067 in a first year.
Henry Meds, often searched as Henry’s Meds, charges $297 a month for compounded semaglutide shots and $179 for liraglutide, and lists tirzepatide only as tablets (checked November 1, 2026).
Pomegranate Health lists compounded tirzepatide at “Starts @ $159/mo,” but its pricing page marked it and semaglutide “Sold Out” on October 24, 2026.
Ivím Health lists compounded semaglutide from $65 a month and tirzepatide from $117, plus a $75 monthly program fee (checked November 1, 2026).
Noom’s compounded tirzepatide plan costs $149 for the first 4 weeks, then $299 a month, billed $897 every 12 weeks (checked November 1, 2026).
OrderlyMeds’ 2-month starter is $149 a month for compounded tirzepatide and $74 for semaglutide, then $299 and $149 a month (checked November 1, 2026).
Raeliva charges $299 a month for compounded tirzepatide, or $242 a month on a 6-month plan paid up front (checked November 1, 2026).
LillyDirect is legit: it’s Eli Lilly’s own online pharmacy service, and Zepbound there costs $299 to $699 a month by dose and refill timing (checked November 1, 2026).
Big Easy Weight Loss lists 12-week compounded tirzepatide packages starting at $469, after a $75 consult it credits or refunds (checked November 1, 2026).
Alloy’s compounded tirzepatide is $199 a month all in at its lowest listed price: $100 for the medication plus a $99 monthly Weight Care fee (checked November 1, 2026).
Henry Meds charges $297 a month for compounded semaglutide shots; 14 of the 15 other online programs here list less, month to month (checked November 1, 2026).
Ro weight loss costs $298 to $448 a month at starting doses: the $149 Ro Body membership plus $149 to $299 for the medicine (checked November 1, 2026).
Hers weight loss costs $298 to $448 a month at starting doses: the $149 membership plus $149 to $299 for the medicine (checked November 1, 2026).
Weight Watchers GLP-1 care costs $223 to $773 a month all in: $74 for Med+ on a 12-month plan, plus $149 to $699 for self-pay medicine (checked November 1, 2026).
LifeRx.md, a telehealth company, is rated 4.8 out of 5 on Trustpilot from 5,604 reviews and lists compounded tirzepatide at $197 a month (checked November 1, 2026).
Trustpilot rates Rx Pros 4.7 out of 5 from 27,362 reviews; its compounded tirzepatide is $144.97 a month paid annually, with a 3-month minimum (checked November 1, 2026).
Trillium Meds is rated 4.6 out of 5 on Trustpilot from 48 reviews; its first-listed compounded tirzepatide is $199 for one month or $499 for three (checked November 1, 2026).
TrimRx is rated 3.4 out of 5 on Trustpilot from 4,922 reviews; its landing page advertises GLP-1 care as low as $149 a month (both read November 1, 2026).
Trinity Meds (trinitymeds.com) is rated 1.4 out of 5 on Trustpilot from 301 reviews, and charges $149 a month for compounded tirzepatide or $99 for semaglutide (checked November 1, 2026).
Willow is rated 4.1 out of 5 on Trustpilot from 382 reviews and charges $299 to $549 a month, by medicine and dose (checked November 1, 2026).
Tirzepatide, semaglutide and the brand names (Zepbound, Mounjaro, Wegovy and Ozempic), plus pills and older options.
Zepbound is FDA-approved brand-name tirzepatide, $299 to $449 a month at LillyDirect (checked November 1, 2026).
A tirzepatide pen injects a preset dose and a vial needs a syringe; LillyDirect sells Zepbound’s KwikPen and vials from $299 a month at 2.5 mg (checked November 1, 2026).
Brand-name semaglutide (Wegovy) is FDA-approved and costs $149 to $399 a month self-pay through NovoCare, by form and dose (checked November 1, 2026); compounded semaglutide isn’t FDA-approved.
There’s no FDA-approved tirzepatide pill as of November 1, 2026; Foundayo and the Wegovy pill are the FDA-approved GLP-1 pills for weight loss.
In SURMOUNT-5, the head-to-head trial, tirzepatide led to more weight loss than semaglutide: 20.2% versus 13.7% on average over 72 weeks (The New England Journal of Medicine, 2025).
Self-pay, Zepbound (FDA-approved tirzepatide for weight loss) is $299 to $449 a month, and Ozempic, for type 2 diabetes and off-label for weight, $349 to $499 (checked November 1, 2026).
Both are Lilly’s tirzepatide: Mounjaro (type 2 diabetes) is $499 a month at LillyDirect, Zepbound (weight, sleep apnea) $299–$449 by dose (November 1, 2026).
Zepbound led to more weight loss in SURMOUNT-5 (2025); Wegovy costs less at most doses, $349 a month self-pay (checked November 1, 2026).
Ozempic is FDA-approved for type 2 diabetes, up to 2 mg a week; Wegovy for weight loss, up to 7.2 mg.
Semaglutide is the medicine; Ozempic is one of its three brand names, FDA-approved for type 2 diabetes, not weight loss (labels checked November 1, 2026).
Both are FDA-approved GLP-1 pills, $149 to $299 a month self-pay (November 1, 2026); only the Wegovy pill needs an empty stomach.
Tirzepatide is a weekly shot; Saxenda is a daily one that Novo Nordisk is discontinuing, with its last shipments to wholesalers in late January 2027.
Head to head, Mounjaro (tirzepatide) lowered A1c and weight more than Trulicity (SURPASS J-mono, 2022) and wasn’t worse on heart events (SURPASS-CVOT, 2025).
Zepbound (tirzepatide), a long-term weekly shot, is $299 to $449 a month at LillyDirect, by dose; phentermine, a short-term stimulant, starts at $15.85 with a GoodRx coupon (November 1, 2026).
Phentermine is a short-term stimulant pill, from $15.85 for 30 tablets with a GoodRx coupon; semaglutide is a GLP-1 for long-term use.
Generic metformin is $9 a month at the starting dose, no coupon needed (November 1, 2026); Ozempic, semaglutide for diabetes, was tested alongside it.
Contrave, a twice-daily pill, is $99 a month through its home-delivery program; Wegovy, a weekly semaglutide shot, is $349 self-pay (November 1, 2026).
No head-to-head result yet: as of November 1, 2026, Lilly hasn’t reported one, and TRIUMPH-5, its trial against tirzepatide, is listed through December 2026 (checked October 25, 2026).
Zepbound ($299–$449 a month) and the Foundayo and Wegovy pills ($149–$299) are FDA-approved Wegovy alternatives, at self-pay prices checked November 1, 2026.
If Zepbound costs too much, your options as of November 1, 2026 are LillyDirect’s self-pay prices ($299–$449), Wegovy pens ($349) and GLP-1 pills ($149–$299).
Yes: as of November 1, 2026, the FDA lists three approved generics of Saxenda (liraglutide) for weight loss and eight of Victoza for type 2 diabetes.
Foundayo (orforglipron) is a daily pill and Zepbound (tirzepatide) a weekly shot; self-pay, Foundayo is $149 to $349 a month and Zepbound $299 to $699 (checked November 1, 2026).
What compounded GLP-1s are, whether they’re legal, who qualifies, and how prescriptions work.
As of November 1, 2026, no clinical trial has tested tirzepatide with B12, and there’s little evidence B12 helps.
Tirzepatide is a once-weekly weight loss injection that acts on two appetite hormones, GIP and GLP-1; as of November 1, 2026, Eli Lilly sells it as Zepbound.
Compounded tirzepatide is made by a state-licensed pharmacy for one prescription and isn’t FDA-approved, so the FDA doesn’t review its safety (checked November 1, 2026).
Yes, compounded tirzepatide is legal when a state-licensed 503A pharmacy prepares it for your prescription and your prescriber documents a significant difference for you.
Semaglutide with B12 is compounded semaglutide with vitamin B12 added, but a 2026 review found limited evidence for adding vitamins without a documented deficiency (checked November 1, 2026).
Compounded semaglutide is prepared by a state-licensed 503A pharmacy for one patient’s prescription; it isn’t FDA-approved.
Yes, as of November 1, 2026, tirzepatide needs a prescription; Zepbound is approved for adults with a BMI of 30 or more, or 27 or more with a weight-related condition.
Tirzepatide research peptides are sold “for research use only,” with no prescription, clinician or pharmacy label, and the FDA urges consumers not to buy them (checked November 1, 2026).
The BMI requirement for tirzepatide (Zepbound) is 30 or more, or 27 or more with a weight-related condition, per its FDA approval on November 8, 2023.
Tirzepatide’s two brand names are Zepbound, for weight loss and sleep apnea, and Mounjaro, for type 2 diabetes; Eli Lilly makes both.
Sublingual tirzepatide is a compounded tablet that dissolves under the tongue; it isn’t FDA-approved, and two programs list it at $229 to $359 month to month (checked November 1, 2026).
No: as of November 1, 2026, no generic semaglutide has final FDA approval, and none is sold in the U.S.
Sublingual semaglutide is a compounded tablet that dissolves under the tongue; it isn’t FDA-approved, and three programs charge $179 to $260 month to month (checked November 1, 2026).
Yes, every semaglutide needs a prescription, from the Wegovy pen and pill, $149 to $399 a month self-pay, to Ozempic, Rybelsus and compounded semaglutide (checked November 1, 2026).
No: as of November 1, 2026, the FDA hasn’t approved any generic tirzepatide, and Lilly lists its U.S. compound patent through 2036.
No, there’s no natural tirzepatide. FDA rules keep approved drugs like it out of supplements, so no “GLP-1” patch, drop or supplement can legally contain it (checked November 1, 2026).
Wegovy’s weight-loss trials enrolled adults with a BMI of 30 or more, or 27 or more with a weight-related condition; its label covers both groups (checked November 1, 2026).
The 2026 labels say: back up birth control pills for 4 weeks after starting tirzepatide and each dose step; stop semaglutide 2 months before pregnancy.
In December 2024, Zepbound became the first FDA-approved medicine for moderate to severe obstructive sleep apnea in adults with obesity; sleep doctors say keep CPAP.
Injecting, dose charts, side effects, results timelines, food, storage and travel.
Units depend on your vial’s strength: in a 30 mg, 3 mL vial (10 mg/mL), 2.5 mg is 25 units on a U-100 syringe (checked November 1, 2026).
Store compounded tirzepatide the way your prescription label says: usually in the fridge at 36°F to 46°F, never frozen (checked November 1, 2026).
Semaglutide dosage on the Wegovy label starts at 0.25 mg weekly and steps up every 4 weeks to the usual 2.4 mg maintenance dose (checked November 1, 2026).
Restarting tirzepatide depends on how long you stopped: Zepbound’s label, read November 1, 2026, says take a missed dose within 4 days, or skip it.
Keep compounded semaglutide in the fridge at 36°F to 46°F, in its box, unless your label says otherwise, and never let it freeze (checked November 1, 2026).
The most common tirzepatide side effects are nausea, diarrhea, vomiting and constipation; in Zepbound’s trials, nausea affected 25% to 29% of people, versus 8% on placebo.
Tirzepatide starts at 2.5 mg and steps up every 4 weeks or more, so the first months are about adjusting.
Draw your prescribed units into a new U-100 insulin syringe and inject under the skin of your stomach or thigh, changing spots every week.
Restarting semaglutide after 2 or more missed weekly doses means a lower dose, back on the steps, per the Wegovy label (read November 1, 2026).
No official chart converts semaglutide to tirzepatide: the Zepbound label, read November 1, 2026, starts everyone at 2.5 mg a week for 4 weeks.
A tirzepatide plateau is normal months in, not in your first 4 weeks: Zepbound’s label, read November 1, 2026, calls 2.5 mg a starting dose.
Yes, tirzepatide can cause hair loss, but it’s usually temporary: dermatologists say hair tends to regain its fullness within 6 to 9 months.
A tirzepatide maintenance dose is 5 mg, 10 mg or 15 mg once a week, per Zepbound’s label (read November 1, 2026); your provider picks yours.
On a GLP-1, put protein first (80 to 120 grams a day, per a 2025 joint advisory) and keep meals small and regular.
Wegovy’s label sets maintenance at 1.7 mg or 2.4 mg weekly, up to 7.2 mg (checked November 1, 2026); nothing lower is labeled for after your goal.
Using a new U-100 insulin syringe, draw your prescribed units and inject under the skin of your stomach, thigh or upper arm, changing spots weekly.
Many of compounded semaglutide’s reported side effects look like Wegovy’s, the FDA says, led by nausea: 44% on Wegovy 2.4 mg in trials, versus 16% on placebo.
Semaglutide hair loss is uncommon: 3.3% of people on Wegovy 2.4 mg reported it in trials, versus 1% on placebo (label, read November 1, 2026).
Sometimes: in SURMOUNT-1 (2022) and SURMOUNT-2 (2023), 5% to 7% of people on Zepbound reported fatigue, versus 3% on placebo, its August 2026 label says.
Zepbound’s and Mounjaro’s labels (revised August 2026) don’t forbid alcohol; drinking may worsen nausea and reflux, and can drop blood sugar with insulin or sulfonylureas.
If you took too much tirzepatide, call 911 for an emergency; otherwise call Poison Control at 1-800-222-1222, then your prescriber (number checked November 1, 2026).
Semaglutide results are gradual: in Wegovy’s 68-week trial, people on 2.4 mg lost 14.9% of their weight on average, versus 2.4% on placebo.
Weight loss on semaglutide slows and levels off over time; before week 17, a stall often just means your dose is still climbing (Wegovy label, checked November 1, 2026).
Flying with tirzepatide is allowed: TSA permits medically necessary liquids, gel ice packs and unused syringes with your medicine in carry-ons, declared at screening (checked November 1, 2026).
Follow your label and prescriber first: refrigerate the vial at 36°F to 46°F, and use it within 28 days of opening, or by its beyond-use date if sooner.
Insurance and Medicare changes, recalls, and the drugs coming next.
Retatrutide is Eli Lilly’s investigational weekly shot, not FDA-approved as of November 1, 2026, so it has no price per month yet.
FDA classified three recalls of compounded GLP-1 injections as Class II from October 8 to 13, 2026.
Foundayo (orforglipron) is Lilly’s once-daily GLP-1 pill for weight loss, FDA-approved April 1, 2026.
Through December 31, 2027, Medicare’s GLP-1 Bridge offers Wegovy, Foundayo or the Zepbound KwikPen for $50 a month to Part D enrollees who qualify; compounded GLP-1s aren’t covered.
In a February–March 2026 survey, 72% of large employers covering GLP-1s for weight loss said they’ll likely keep coverage in 2027 and 10% likely won’t (Business Group on Health).
For 2027, FEHB and PSHB plans keep covering at least one weight-loss GLP-1 but will require documented behavioral therapy, OPM says; Open Season ends December 14, 2026.
Novo Nordisk expects an FDA decision on CagriSema in Q4 2026, and Lilly plans to submit retatrutide in Q1 2027, the companies say.
CagriSema, Novo Nordisk’s weekly cagrilintide-semaglutide shot, isn’t FDA-approved as of November 1, 2026; Novo expects a decision in Q4 2026.
Each state guide covers that state’s Medicaid coverage, its pharmacy and telehealth rules, and online prices.
Shorter reads and updates from the NexLife team.
Online semaglutide pricing in 2026 depends on whether you use brand-name (Wegovy or Ozempic) or, where legally available, compounded semaglutide — plus dose, provider review, pharmacy ful...
Comparamos 10 proveedores de tirzepatida y semaglutida en línea con las mismas seis pruebas.
De los 10 programas de tirzepatida en línea que probamos, PreventiveMD tiene el precio mes a mes más bajo ($139 en cada dosis), consultado el 1 de noviembre de 2026.
De los 10 mejores proveedores de semaglutida que probamos, PreventiveMD cobra menos mes a mes: $119 en cada dosis (consultado el 1 de noviembre de 2026).
Our prices, whether NexLife is legit, and how we compare programs.
NexLife’s prices, as of November 1, 2026: compounded tirzepatide is $139 a month on the 12-month plan or $169 month to month.
Yes, NexLife is legit: it’s LegitScript-certified, and it’s rated 4.8 out of 5 on Trustpilot from 407 reviews (read November 1, 2026).
Our GLP-1 provider guides compare programs on six tests, and our program ratings score seven, with prices read on each program’s own site, last fully checked November 1, 2026.
NexLife uses two state-licensed 503A partner pharmacies: Absolute Pharmacy in Lutz, Florida, and Boudreaux’s New Drug Store in Lake Charles, Louisiana (checked November 1, 2026).
NexLife is available in each state on this page’s list, at the same price: compounded tirzepatide is $139 a month on the 12-month plan (checked November 1, 2026).
Each guide shows when its prices were checked and lists its sources. Programs change their prices often, so the date matters.
Doses, safety and results come from FDA labels and published clinical trials, linked in each guide.
Comparisons put every program, NexLife included, through the same tests, and say at the top that NexLife publishes them. How we compare programs.
Each guide names its medical reviewer and the date it was last updated.
Start with cost and the medication itself: read how much tirzepatide costs per month, then tirzepatide vs. semaglutide. If you’re choosing a program, the provider comparisons rate each one on price, fees and care, and the state guides explain your state’s rules.
Each guide shows the date its prices were checked and links its sources: the providers’ own websites, FDA labels and published clinical trials. Programs change their prices often, so check the date next to any price, and the provider’s own site, before you decide.
No. A state-licensed pharmacy prepares compounded tirzepatide or semaglutide for one person, on a prescription, and the FDA doesn’t approve compounded drugs. Zepbound, Mounjaro, Wegovy and Ozempic are FDA-approved brand-name medicines. Our compounded vs. brand-name guides for tirzepatide and semaglutide compare their prices, FDA status and where to get each.
The NexLife Medical Team writes them and reviews them medically, led by Adam Kennah, MD, NexLife’s medical director. NexLife is a telehealth and care-coordination platform and earns revenue when people join, so each comparison says that at the top and puts every program, NexLife included, through the same tests. Each guide shows its reviewer and the date it was updated.
Compounded tirzepatide at NexLife is $139 a month on the 12-month plan, or $169 month to month. Compounded semaglutide is $119 a month on the 12-month plan, or $139 month to month. The same price at every dose, with no membership fee.
Price Match Guarantee†: paying less with another licensed provider? We match your regular monthly price.
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. †Terms apply: see Price Match Guarantee† terms.
